Wikipedia -WSS

Wikipedia

author：fashion 2025-09-05 06:02:52 - browse：33744

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： ProMED, early warning system on disease outbreaks, in peril

WSS

OTC birth control: A brief history of over the counter pill design

Microsoft strikes partnership with Duke Health to advance health AI

David Liu startup to focus on CRISPR delivery

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Nearly two

ER docs worry over extreme heat as a 'mass casualty event'

hotspot

Wikipedia

Wikipedia

Sports medicine is finally prioritizing gender equality

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Duchenne breakthrough therapy leaves behind pioneering families

Midwives could help bridge maternal health disparities in the U.S.

Duchenne breakthrough therapy leaves behind pioneering families

Biden calls for immediate release of Niger's president amid apparent coup

United colonoscopy coverage change 'may cost lives,' doctors say

Transgender sports debate: Physicians say bans are health issue

Apple is now the first public company to be valued at $3 trillion

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

hotspot

Neurocrine congenital adrenal hyperplasia trial succeeds

How the messy conversation about Dolly changed bioethics

Why the quest to eradicate polio has stumbled

Neurocrine congenital adrenal hyperplasia trial succeeds

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Why the drug industry's warnings on the IRA's impact fall short

explore

hotspot

knowledge

focus